Find Federal Grants
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AA-21-003
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AA-21-004
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AA-21-002
Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health
Centers for Disease Control - OSTLTS · CDC-RFA-OT18-18020301SUPP21
High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-DA-22-006
Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required)
National Institutes of Health · RFA-AG-22-011
Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional)
National Institutes of Health · RFA-TR-21-009
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
Agency for Health Care Research and Quality · PA-21-158
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-22-004
Zambia USAID-Lusaka · 72061121RFA00001
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)
National Institutes of Health · PAR-21-145
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)
National Institutes of Health · PAR-21-144
Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional)
National Institutes of Health · PAR-21-117
Limited Competition for the Continuation of Multisite Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Optional)
National Institutes of Health · PAR-21-116
U.S. Mission to Japan · TOKYO-PAS-FY21-01-12
U.S. Mission to Japan · TOKYO-PAS-FY21-01-08
Defense Health Agency · 22-DHA-MHSR
Centers for Disease Control - NCIPC · CDC-RFA-CE21-2103
The Cellular Scale Connectome in Aging and Alzheimers Disease (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AG-22-008
Burma USAID - Rangoon · 72048221RFA00002